The 2016 and 2017 National Immunization Surveys-Teen (NIS-Teen) highlighted disparities in human papillomavirus (HPV) vaccination coverage by metropolitan statistical area (MSA) status. Coverage with 651 dose of HPV vaccine was significantly lower among teens in suburban and mostly rural areas than it was among those in mostly urban areas. Reasons underlying this disparity are poorly understood; this analysis sought to identify sociodemographic factors associated with not initiating the HPV vaccine series and to determine whether these factors differed by MSA status. Using NIS-Teen data for a sample of 41,424 adolescents from the 2016 and 2017 survey years, multivariate logistic regression was utilized to assess associations between variou...
BACKGROUND: Schools are the primary setting for the delivery of adolescent HPV vaccination in Austra...
Abstract Background This study is the first to examine associations between several area-based socio...
Objective: Adolescent females' HPV vaccine completion in the U.S. is low. More recent research is ne...
Disparities in HPV vaccination coverage by metropolitan statistical area (MSA) status were observed ...
Human papillomavirus (HPV) is associated with 37,300 new cases of cancer every year in the United St...
Introduction: Cervical cancer and Human papillomavirus (HPV) affects women, men, and children of all...
Background: Vaccines against human papillomavirus (HPV) were approved in 2006, but uptake has been l...
Background: Approximately 46,000 cases of human papillomavirus (HPV) attributable cancers are diagno...
INTRODUCTION: Human Papilloma Virus (HPV) is a highly contagious virus known to cause many cancers ...
Background: Several studies have reported differential vaccine uptake outcomes that are associated w...
The most important determinant of HPV vaccination uptake is healthcare provider recommendation, yet ...
Abstract Background Human Papillomavirus (HPV) vaccination coverage is below national goals in the U...
Adolescent uptake of human papillomavirus (HPV) vaccine remains low. We evaluated HPV vaccine uptake...
Adolescent uptake of human papillomavirus (HPV) vaccine remains low. We evaluated HPV vaccine uptake...
Low human papillomavirus (HPV) vaccination coverage is an urgent public health problem requiring act...
BACKGROUND: Schools are the primary setting for the delivery of adolescent HPV vaccination in Austra...
Abstract Background This study is the first to examine associations between several area-based socio...
Objective: Adolescent females' HPV vaccine completion in the U.S. is low. More recent research is ne...
Disparities in HPV vaccination coverage by metropolitan statistical area (MSA) status were observed ...
Human papillomavirus (HPV) is associated with 37,300 new cases of cancer every year in the United St...
Introduction: Cervical cancer and Human papillomavirus (HPV) affects women, men, and children of all...
Background: Vaccines against human papillomavirus (HPV) were approved in 2006, but uptake has been l...
Background: Approximately 46,000 cases of human papillomavirus (HPV) attributable cancers are diagno...
INTRODUCTION: Human Papilloma Virus (HPV) is a highly contagious virus known to cause many cancers ...
Background: Several studies have reported differential vaccine uptake outcomes that are associated w...
The most important determinant of HPV vaccination uptake is healthcare provider recommendation, yet ...
Abstract Background Human Papillomavirus (HPV) vaccination coverage is below national goals in the U...
Adolescent uptake of human papillomavirus (HPV) vaccine remains low. We evaluated HPV vaccine uptake...
Adolescent uptake of human papillomavirus (HPV) vaccine remains low. We evaluated HPV vaccine uptake...
Low human papillomavirus (HPV) vaccination coverage is an urgent public health problem requiring act...
BACKGROUND: Schools are the primary setting for the delivery of adolescent HPV vaccination in Austra...
Abstract Background This study is the first to examine associations between several area-based socio...
Objective: Adolescent females' HPV vaccine completion in the U.S. is low. More recent research is ne...